Gene delivery device "MaxCyte STX"
Capable of processing from small quantities to large quantities! A gene introduction device applicable from basic research to clinical use.
The "MaxCyte STX" is a cell transfection device from MaxCyte, Inc. that can process a large number of cells at once (capable of transfecting 100 million cells). MaxCyte's transfection technology is based on the general principle of electroporation, which enhances temporary membrane permeability by generating an electric field in a cell suspension to introduce external substances such as DNA into the cells. The "MaxCyte STX" utilizes this fundamental principle and is a patented electroporation system that is simple and flexible, allowing for processing from small to large scales. 【Features】 - Simplicity and flexibility of the system enabling processing from small to large scales - Stable transfection performance → High transfection efficiency and cell viability - Wide range of applications → From basic research to clinical applications For more details, please contact us or download the catalog.
- Company:BTB Japan
- Price:Other